Javascript must be enabled to continue!
Addressing overdose risk among recently incarcerated people living with HIV
View through CrossRef
Introduction As the opioid overdose crisis enters its third decade, certain groups are disproportionately impacted. Some, such as those exiting incarceration and people living with HIV (PLWH), have always been at increased risk for a fatal opioid overdose. Others, such as those who use non-opioids, may be newly at risk due to fentanyl contamination of non-opioid street drugs. There is an urgent need to provide overdose education and naloxone distribution (OEND) and other harm reduction interventions to these groups; however, little is known about risk reduction needs specific to these groups. Methods OEND trainings were given to incarcerated PLWH inside the Philadelphia Department of Prisons. Qualitative interviews about OEND training, overdose experiences, and other harm reduction behaviors were conducted with formerly incarcerated PLWH who used illegal drugs before and after their most recent incarceration. Results OEND trainings were given to 120 incarcerated PLWH and 18 PLWH with a history of incarceration participated in qualitative interviews about OEND training experiences; analysis of needs specific to people who use non-opioids was conducted with the 15 of 18 qualitative participants who used non-opioids. Incarcerated people who received OEND training demonstrated improved overdose knowledge and attitudes about managing a witnessed overdose. Most participants had witnessed overdoses before and after their most recent incarceration and cited altruism as a motive for receiving OEND training and for helping other people. These same participants, however, expressed concern that assisting during an overdose may jeopardize their liberty due to potential interaction with law enforcement. OEND trainings as delivered did not appear to adequately heighten participant concerns about their own potential for experiencing an opioid overdose. This was especially true among those who use non-opioid drugs, despite knowing that the drug market was shifting and there was potential for non-opioid drugs to be contaminated with fentanyl. These same participants believed they would have difficulty recognizing an overdose in someone they perceived as using only non-opioids. All qualitative participants indicated a willingness to use harm reduction techniques to stay safer when using drugs, including a willingness on the part of people who use non-opioids to utilize fentanyl test strips. Conclusion Addressing overdose risk among people who are being released from correctional facilities is a complex process that involves a targeted approach to fully address the unique needs of this population. OEND trainings in correctional settings are feasible and acceptable for incarcerated people. However, formerly incarcerated people have concerns related to assisting in an overdose due to a desire to avoid contact with law enforcement. OEND trainings should address these needs.
Title: Addressing overdose risk among recently incarcerated people living with HIV
Description:
Introduction As the opioid overdose crisis enters its third decade, certain groups are disproportionately impacted.
Some, such as those exiting incarceration and people living with HIV (PLWH), have always been at increased risk for a fatal opioid overdose.
Others, such as those who use non-opioids, may be newly at risk due to fentanyl contamination of non-opioid street drugs.
There is an urgent need to provide overdose education and naloxone distribution (OEND) and other harm reduction interventions to these groups; however, little is known about risk reduction needs specific to these groups.
Methods OEND trainings were given to incarcerated PLWH inside the Philadelphia Department of Prisons.
Qualitative interviews about OEND training, overdose experiences, and other harm reduction behaviors were conducted with formerly incarcerated PLWH who used illegal drugs before and after their most recent incarceration.
Results OEND trainings were given to 120 incarcerated PLWH and 18 PLWH with a history of incarceration participated in qualitative interviews about OEND training experiences; analysis of needs specific to people who use non-opioids was conducted with the 15 of 18 qualitative participants who used non-opioids.
Incarcerated people who received OEND training demonstrated improved overdose knowledge and attitudes about managing a witnessed overdose.
Most participants had witnessed overdoses before and after their most recent incarceration and cited altruism as a motive for receiving OEND training and for helping other people.
These same participants, however, expressed concern that assisting during an overdose may jeopardize their liberty due to potential interaction with law enforcement.
OEND trainings as delivered did not appear to adequately heighten participant concerns about their own potential for experiencing an opioid overdose.
This was especially true among those who use non-opioid drugs, despite knowing that the drug market was shifting and there was potential for non-opioid drugs to be contaminated with fentanyl.
These same participants believed they would have difficulty recognizing an overdose in someone they perceived as using only non-opioids.
All qualitative participants indicated a willingness to use harm reduction techniques to stay safer when using drugs, including a willingness on the part of people who use non-opioids to utilize fentanyl test strips.
Conclusion Addressing overdose risk among people who are being released from correctional facilities is a complex process that involves a targeted approach to fully address the unique needs of this population.
OEND trainings in correctional settings are feasible and acceptable for incarcerated people.
However, formerly incarcerated people have concerns related to assisting in an overdose due to a desire to avoid contact with law enforcement.
OEND trainings should address these needs.
Related Results
HIV WGS - 400bp Amplicon Tiling - Oxford Nanopore Technology Protocol v1
HIV WGS - 400bp Amplicon Tiling - Oxford Nanopore Technology Protocol v1
OSPHL in collaboration with APHL, will evaluate the performance of the Oxford Nanopore Technology sequencers for HIV genome sequencing using a modified protocol of the ARTIC amplic...
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract
Introduction
Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
The Women Who Don’t Get Counted
The Women Who Don’t Get Counted
Photo by Hédi Benyounes on Unsplash
ABSTRACT
The current incarceration facilities for the growing number of women are depriving expecting mothers of adequate care cruci...
Pregnant Prisoners in Shackles
Pregnant Prisoners in Shackles
Photo by niu niu on Unsplash
ABSTRACT
Shackling prisoners has been implemented as standard procedure when transporting prisoners in labor and during childbirth. This procedure ensu...
Drug overdose among female participants of a harm reduction program in Philadelphia
Drug overdose among female participants of a harm reduction program in Philadelphia
Introduction: In the past two decades, women's rates of fatal drug overdose tripled and nonfatal overdose has been common among women who use illicit drugs. While research has focu...
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
A infecção pelo vírus do HIV pode ocorrer de diversas maneiras, tendo sua principal forma a via sexual por meio do sexo desprotegido. O vírus do HIV fica em um período de incubação...
A Large-Scale Observational Study on the Temporal Trends and Risk Factors of Opioid Overdose: Real-World Evidence for Better Opioids
A Large-Scale Observational Study on the Temporal Trends and Risk Factors of Opioid Overdose: Real-World Evidence for Better Opioids
Abstract
Background
The United States is in the midst of an opioid overdose epidemic. We evaluated the temporal trends and risk...
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Background: HIV rapid diagnosis in The Gambia is mainly done using Determine HIV-1/2 and First Response HIV 1.2.0 or SD Bioline HIV-1/2 3.0 for screening and sero-typing of HIV res...

